Coffee Consumption and NASH in the French Population.
NCT03432377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107
Last updated 2021-01-28
Summary
The aim of our study is to evaluate the effect of coffee consumption on the risk of severe liver fibrosis in French patients with NASH.
Conditions
- Non Alcoholic Steatohepatitis
Sponsors & Collaborators
-
Versailles Hospital
lead OTHER
Principal Investigators
-
Hugues BLONDON, Department head · Versailles Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-15
- Primary Completion
- 2020-11-17
- Completion
- 2020-11-17
Countries
- France
Study Locations
More Related Trials
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis
NCT06160271 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
NCT03173287 ·Status: UNKNOWN ·Phase: NA
-
Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of Strasbourg
NCT04282447 ·Status: UNKNOWN
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
Prospective Cohort of Patients With Hepatocellular Carcinoma in France
NCT04348838 ·Status: RECRUITING
-
NASH and Coronary Disease
NCT03819283 ·Status: UNKNOWN ·Phase: NA
-
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
NCT06634160 ·Status: RECRUITING
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
NCT06814600 ·Status: RECRUITING
-
: Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University Hospital
NCT06738810 ·Status: COMPLETED ·Phase: NA
-
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884 ·Status: COMPLETED
-
Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas
NCT03382327 ·Status: COMPLETED ·Phase: NA
-
Identification of Protective and Worsening Steatohepatitis (NASH) Factors
NCT00914446 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
NCT07303140 ·Status: RECRUITING
-
Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic Steatohepatitis
NCT06152250 ·Status: RECRUITING ·Phase: NA
-
Transient Elastography and Variceal Bleeding
NCT00635687 ·Status: TERMINATED ·Phase: NA
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT05623150 ·Status: RECRUITING
-
Use of the French Healthcare Insurance Database
NCT02983968 ·Status: UNKNOWN
-
Impact of Hepatitis C Virus Variability on Steatosis
NCT00843076 ·Status: TERMINATED
-
Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH
NCT02820285 ·Status: COMPLETED ·Phase: NA
-
Validation in a Non-targeted Population of Single Ultrasound Doppler Signs of Liver Fibrosis
NCT03027921 ·Status: UNKNOWN ·Phase: NA
-
Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis C
NCT00399815 ·Status: UNKNOWN
-
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
NCT03725631 ·Status: UNKNOWN ·Phase: NA